We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Relay Therapeutics
RLAY
$3.99B
| $1.8M | ﹤0.01% |
+276,702
| New | +$1.89M |
|
|
BCYC
1402
Bicycle Therapeutics
BCYC
$275M
| $1.8M | ﹤0.01% |
+88,987
| New | +$2.01M |
|
1403
TScan Therapeutics
TCRX
$50.6M
| $1.8M | ﹤0.01% |
307,487
+116,316
| +61% | +$916K |
|
1404
ProFrac Holding
ACDC
$671M
| $1.8M | ﹤0.01% |
242,491
+228,491
| +1,632% | +$1.89M |
|
1405
PUT
iShares MSCI South Korea ETF
EWY
$21.1B
| $1.79M | ﹤0.01% |
27,100
+21,300
| +367% | +$1.37M |
|
|
DRD
1406
DRDGold
DRD
$1.79B
| $1.79M | ﹤0.01% |
208,006
+53,081
| +34% | +$449K |
|
1407
RXO
RXO
$3.73B
| $1.79M | ﹤0.01% |
+68,455
| New | +$1.42M |
|
1408
Capital Group Dividend Value ETF
CGDV
$37.3B
| $1.79M | ﹤0.01% |
+54,212
| New | +$1.77M |
|
1409
StealthGas
GASS
$329M
| $1.78M | ﹤0.01% |
242,851
-33,067
| -12% | -$228K |
|
1410
LegalZoom.com
LZ
$1.39B
| $1.78M | ﹤0.01% |
+212,626
| New | +$2.19M |
|
|
MZTI
1411
The Marzetti Company
MZTI
$3.02B
| $1.77M | ﹤0.01% |
9,360
+7,051
| +305% | +$1.35M |
|
|
PPBI
1412
DELISTED
Pacific Premier Bancorp
PPBI
| $1.76M | ﹤0.01% |
+76,699
| New | +$1.7M |
|
1413
Taysha Gene Therapies
TSHA
$1.57B
| $1.76M | ﹤0.01% |
786,094
-244,563
| -24% | -$712K |
|
1414
Heartland Express
HTLD
$1.04B
| $1.76M | ﹤0.01% |
142,774
+64,522
| +82% | +$721K |
|
1415
Century Aluminum
CENX
$4.35B
| $1.76M | ﹤0.01% |
+104,840
| New | +$1.78M |
|
1416
News Corp Class A
NWSA
$15.3B
| $1.75M | ﹤0.01% |
63,346
-85,744
| -58% | -$2.22M |
|
|
HPP
1417
Hudson Pacific Properties
HPP
$765M
| $1.75M | ﹤0.01% |
51,864
+47,656
| +1,133% | +$1.8M |
|
1418
Freshworks
FRSH
$3.09B
| $1.74M | ﹤0.01% |
+137,100
| New | +$2.05M |
|
1419
Ameresco
AMRC
$1.04B
| $1.73M | ﹤0.01% |
60,210
+30,497
| +103% | +$841K |
|
1420
Braskem
BAK
$944M
| $1.73M | ﹤0.01% |
268,352
+240,744
| +872% | +$1.92M |
|
|
KW
1421
DELISTED
Kennedy-Wilson Holdings
KW
| $1.72M | ﹤0.01% |
+177,099
| New | +$1.66M |
|
|
ILPT
1422
Industrial Logistics Properties Trust
ILPT
$603M
| $1.72M | ﹤0.01% |
467,568
-33,265
| -7% | -$129K |
|
1423
Magnachip Semiconductor
MX
$118M
| $1.71M | ﹤0.01% |
351,907
-452,551
| -56% | -$2.28M |
|
1424
Nu Skin
NUS
$255M
| $1.71M | ﹤0.01% |
162,477
-200,566
| -55% | -$2.54M |
|
1425
iShares MSCI Italy ETF
EWI
$993M
| $1.7M | ﹤0.01% |
+47,524
| New | +$1.78M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.